enow.com Web Search

  1. Ads

    related to: new peptide drugs for osteoporosis

Search results

  1. Results from the WOW.Com Content Network
  2. Teriparatide - Wikipedia

    en.wikipedia.org/wiki/Teriparatide

    Teriparatide is indicated for the treatment of postmenopausal women with osteoporosis; [13] for the increase of bone mass in men with primary or hypogonadal osteoporosis; [13] and treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy.

  3. Abaloparatide - Wikipedia

    en.wikipedia.org/wiki/Abaloparatide

    Abaloparatide, sold under the brand name Tymlos among others, is a parathyroid hormone-related protein (PTHrP) analog medication used to treat osteoporosis. [1] It is an anabolic (i.e., bone growing) agent.

  4. Recombinant human parathyroid hormone - Wikipedia

    en.wikipedia.org/wiki/Recombinant_human...

    Recombinant human parathyroid hormone (Natpara) is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in people with hypoparathyroidism. [1] [2] Recombinant human parathyroid hormone (Natpar) is indicated as adjunctive treatment of adults with chronic hypoparathyroidism who cannot be adequately controlled with standard therapy alone.

  5. First osteoporosis drug of its kind for more than a decade ...

    www.aol.com/first-osteoporosis-drug-kind-more...

    The drug is one of only two treatments that help to promote bone formation, and the first to reduce bone loss at the same time. First osteoporosis drug of its kind for more than a decade approved ...

  6. Merck Announces Osteoporosis Drug Success - AOL

    www.aol.com/2012/10/15/merck-announces-new-drug...

    Pharmaceutical giant Merck (NYS: MRK) reported promising results from a phase II drug trial for its new osteoporosis drug, odanacatib. Merck plans to submit applications for the drug to U.S ...

  7. Zoledronic acid - Wikipedia

    en.wikipedia.org/wiki/Zoledronic_acid

    Zoledronic acid is used for the treatment of osteoporosis in men and post-menopausal women at increased risk of fracture. [13] [14] In 2007, the US Food and Drug Administration (FDA) approved zoledronic acid for the treatment of postmenopausal osteoporosis. [7] [15]

  8. Palopegteriparatide - Wikipedia

    en.wikipedia.org/wiki/Palopegteriparatide

    The US Food and Drug Administration (FDA) prescription label for palopegteriparatide includes warnings for a potential risk of risk of unintended changes in serum calcium levels related to number of daily injections and total delivered dose, serious hypocalcemia and hypercalcemia (blood calcium levels that are too high), osteosarcoma (a rare bone cancer) based on findings in rats, orthostatic ...

  9. How to preserve muscle mass on weight-loss drugs like Wegovy

    www.aol.com/preserve-muscle-mass-weight-loss...

    The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss ...

  1. Ads

    related to: new peptide drugs for osteoporosis